Refresher Course: Hybrid, Molecular and Translational Imaging
RC 1706 - Essential non-FDG tracers
Lectures
1
Chairperson's introduction
05:00Aleksandar Milosevic, Essen / DE
2
PSMA: more than just prostate
15:00Amy Eccles, London / UK
3
FAPI: the key to the tumour microenvironment?
15:00Wolfgang Roll, Münster / DE
4
DOTATATE: theranostic applications
15:00Jose Luis Vercher Conejero, Barcelona / ES
5
Panel discussion: How specific can we get? How many tracers do we actually need?
10:00Panel discussion: How specific can we get? How many tracers do we actually need?
5 min
Chairperson's introduction
Aleksandar Milosevic, Essen / Germany
15 min
PSMA: more than just prostate
Amy Eccles, London / United Kingdom
- To appreciate the biological characteristics and function of PSMA.
- To learn about the principles of PSMA tracer chemistry and its characteristics.
- To understand how PSMA PET application could be broadened beyond prostate cancer.
15 min
FAPI: the key to the tumour microenvironment?
Wolfgang Roll, Münster / Germany
- To learn about the biology and chemistry behind FAPI PET.
- To appreciate the potential of FAPI as a tracer in conventional therapy and immunotherapy.
- To understand how FAPI and comparable tracers can alter oncologic imaging.
15 min
DOTATATE: theranostic applications
Jose Luis Vercher Conejero, Barcelona / Spain
- To learn about neuroendocrine tumour imaging using DOTATATE.
- To appreciate the potential of targeted therapy.
- To understand the principles of theranostics, exemplified in DOTATATE PET and therapy.
10 min
Panel discussion: How specific can we get? How many tracers do we actually need?